This review focuses on the current state of research on the interplay of inflammation and oxidative stress in obesity, the role of the Nrf2 pathway in obesity and insulin resistance, and the potential use of Nrf2 activators for the treatment of insulin resistance. This evidence concerns the gene NFE2L2 and obesity due to melanocortin 4 receptor deficiency.